Levetiracetam Extended Release

Nivagen Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 14, 2023
Approval ID: dcc6229b-2203-4a4d-8d41-bf7e4ff830ce
Products: 2 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LEVETIRACETAM EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for LEVETIRACETAM EXTENDED-RELEASE TABLETS. LEVETIRACETAM Extended-Release Tablets, for oral use Initial U.S. Approval: 1999

Quick Stats

Total Products2

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.